To evaluate the use of prostatic artery embolization (PAE) as a treatment option for patients with symptomatic benign prostatic hyperplasia (BPH) with prostate volumes of 80 cc and more.
The study included 75 patients with high anesthesia-related risks for conventional surgery (TURP).